论文部分内容阅读
深圳长白山制药实业有限公司生产的乳增宁片为卫生部批准的国家级三类新中成药,综合治疗乳腺增生症和乳痛症有效率达96.23％,并对阻止乳腺癌变的发生具有积极的意义。该药投放市场几年来,以其组方独特、疗效显著、安全无毒和价格低廉等特点,受到乳腺增生患者的欢迎。该药不仅在1995年被卫生部列为国家中药
The milk granules produced by Shenzhen Changbai Mountain Pharmaceutical Industry Co., Ltd. are national grade three new Chinese patent medicines approved by the Ministry of Health. The comprehensive treatment of hyperplasia of mammary glands and mastodynia is 96.23% efficient, and it has positive effects on preventing the onset of breast cancer. significance. Since the drug was put on the market in the past few years, it has been welcomed by patients with hyperplasia of mammary gland due to its unique features, remarkable efficacy, safety, non-toxicity, and low price. The drug was not only listed as a national Chinese medicine by the Ministry of Health in 1995.